Resurgent Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
5,944
+1,998
+51% +$430K 0.42% 54
2026
Q1
$858K Buy
3,946
+1,192
+43% +$264K 0.31% 78
2025
Q4
$629K Sell
2,754
-24
-0.9% -$5.47K 0.32% 94
2025
Q3
$643K Sell
2,778
-63
-2% -$12.8K 0.32% 92
2025
Q2
$527K Sell
2,841
-17
-0.6% -$3.16K 0.29% 102
2025
Q1
$599K Sell
2,858
-393
-12% -$76.4K 0.36% 77
2024
Q4
$578K Buy
3,251
+42
+1% +$7.72K 0.34% 87
2024
Q3
$634K Buy
3,209
+598
+23% +$112K 0.37% 79
2024
Q2
$448K Buy
2,611
+57
+2% +$9.44K 0.28% 109
2024
Q1
$465K Sell
2,554
-100
-4% -$17.2K 0.25% 111
2023
Q4
$411K Sell
2,654
-454
-15% -$66.2K 0.25% 104
2023
Q3
$463K Buy
3,108
+7
+0.2% +$1.03K 0.32% 82
2023
Q2
$418K Buy
3,101
+147
+5% +$21.6K 0.28% 84
2023
Q1
$471K Sell
2,954
-3,837
-57% -$587K 0.31% 83
2022
Q4
$1.1M Sell
6,791
-512
-7% -$78.5K 0.58% 39
2022
Q3
$980K Buy
7,303
+231
+3% +$33.1K 0.66% 42
2022
Q2
$1.08M Buy
7,072
+454
+7% +$69.4K 0.69% 40
2022
Q1
$1.07M Buy
6,618
+3,973
+150% +$577K 0.67% 36
2021
Q4
$358K Buy
+2,645
New +$312K 0.29% 85

Other funds holding ABBV

Resurgent Financial Advisors's ABBV Position: Q2 2026 in Review

Resurgent Financial Advisors increased its AbbVie (ABBV) stake by 51% in Q2 2026, buying an estimated $430K and bringing the position to 5,944 shares worth $1.5M. The position accounts for 0.42% of the portfolio, ranked #54.

Resurgent Financial Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Resurgent Financial Advisors held 5,944 shares of AbbVie worth $1.5M as of Q2 2026.
  • Resurgent Financial Advisors bought 1,998 AbbVie shares in Q2 2026, an estimated $430K.
  • AbbVie made up 0.42% of Resurgent Financial Advisors's portfolio in Q2 2026, its #54 holding.
  • Resurgent Financial Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Resurgent Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.